Loading...
Optiscan Imaging Limited
OIL.AX•ASX
TechnologyHardware, Equipment & Parts
$0.13
$-0.01(-3.85%)
Optiscan Imaging Limited (OIL.AX) Stock Overview
Explore Optiscan Imaging Limited’s financial performance, market position, analyst ratings, and future outlook.
Revenue Growth
-31.22%
↓ 31.22%
Profit Growth
$-0.01
↓ 39.27%
EPS Growth
$-0.01
↓ 5.71%
Operating Margin
-98.06%
↓ 13.79%
ROE
-39.12%
↓ 39.27%
Dividend Yield
0.00%
Analyst Recommendations data is not available for OIL.AXAnalyst Recommendations details for OIL.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Company Profile
Optiscan Imaging Limited develops and commercializes confocal microscopes for clinical and pre-clinical applications in Australia, Germany, and Internationally. It offers FIVE2 (ViewnVivo) system, a miniaturized confocal endomicroscopes use for clinical, translational, pre-clinical, and other research. The company also engages in the development of InVivage device for use in cancer screening and surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.
CEO
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D.
Employees
8
Headquarters
16 Miles St, Mulgrave, VIC
Founded
1997